Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1145864
PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1145864
Non-Melanoma Skin Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Contact us about how to customize the report with add-on data.
The global non-melanoma skin cancer treatment market size reached US$ 504.6 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 692.9 Million by 2027, exhibiting a growth rate (CAGR) of 5.54% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemicon different end use sectors. These insights are included in the report as a major market contributor.
Non-melanoma skin cancer (NMSC) refers to the abnormal growth of malignant cells in the upper layer of the skin. Some of the common types of NMSC include basal cell, merkle cell and squamous cell carcinoma and cutaneous T-cell lymphoma. It is primarily characterized by the development of firm lumps or scaly patches on the skin. The treatment methodologies involve the removal of cancer cells through surgical procedures, including micrographic surgery, laser therapy and cryotherapy, and various non-surgical treatments, such as photodynamic therapy (PDT), radiotherapy and electrotherapy.
The increasing prevalence of skin cancer and the rising geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the available treatment alternatives for NMSC is also stimulating the market growth. In comparison to the traditionally used therapies, superficial radiation therapy has reduced side-effects on the patient's body and can be conducted through innovative portable devices. These devices are also used for early diagnosis of skin lesions with high accuracy and sensitivity. Additionally, various technological advancements, such as the development of electronic brachytherapy (eBx), are acting as other growth-inducing factors. eBx is a painless and non-invasive targeted low-energy radiation therapy that requires a shorter treatment course and minimizes the risks of radiation exposure to the nearby healthy tissues. Other factors, including rising healthcare expenditures of individuals and government funding for clinical trials, along with extensive research and development (R&D) activities, are anticipated to drive the market further.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global non-melanoma skin cancer treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on treatment type, indication and end use.
Breakup by Treatment Type:
- Chemotherapy
- Radiation Therapy
- Photodynamic Therapy
- Others
Breakup by Indication:
- Basal Cell Carcinoma
- T-Cell Lymphoma
- Squamous Cell Carcinoma
- Others
Breakup by End Use:
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The report has also analysed the competitive landscape of the market with some of the key players being Accuray Incorporated, Almirall S.A., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Elekta AB, Eli Lilly and Company, F. Hoffmann-La Roche AG, Icad Inc., Merck & Co. Inc., Novartis AG, Sun Pharmaceutical Industries Limited and Varian Medical Systems Inc.
Key Questions Answered in This Report:
- How has the global non-melanoma skin cancer treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global non-melanoma skin cancer treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global non-melanoma skin cancer treatment market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR1122A377_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Non-Melanoma Skin Cancer Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Treatment Type
- 6.1 Chemotherapy
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Radiation Therapy
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Photodynamic Therapy
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Indication
- 7.1 Basal Cell Carcinoma
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 T-Cell Lymphoma
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Squamous Cell Carcinoma
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End Use
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Specialty Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Ambulatory Surgery Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Accuray Incorporated
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Almirall S.A.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Boehringer Ingelheim GmbH
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 SWOT Analysis
- 14.3.4 Bristol-Myers Squibb Company
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Elekta AB
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Eli Lilly and Company
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 F. Hoffmann-La Roche AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 SWOT Analysis
- 14.3.8 Icad Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Merck & Co. Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Novartis AG
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Sun Pharmaceutical Industries Limited
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Varian Medical Systems Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.1 Accuray Incorporated
Product Code: SR1122A377_Report
List of Figures
- Figure 1: Global: Non-Melanoma Skin Cancer Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016-2021
- Figure 3: Global: Non-Melanoma Skin Cancer Treatment Market: Breakup by Treatment Type (in %), 2021
- Figure 4: Global: Non-Melanoma Skin Cancer Treatment Market: Breakup by Indication (in %), 2021
- Figure 5: Global: Non-Melanoma Skin Cancer Treatment Market: Breakup by End Use (in %), 2021
- Figure 6: Global: Non-Melanoma Skin Cancer Treatment Market: Breakup by Region (in %), 2021
- Figure 7: Global: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 8: Global: Non-Melanoma Skin Cancer Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 9: Global: Non-Melanoma Skin Cancer Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 10: Global: Non-Melanoma Skin Cancer Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11 Global: Non-Melanoma Skin Cancer Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 12: Global: Non-Melanoma Skin Cancer Treatment (Photodynamic Therapy) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 13: Global: Non-Melanoma Skin Cancer Treatment (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 14: Global: Non-Melanoma Skin Cancer Treatment (Other Treatment Types) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 15: Global: Non-Melanoma Skin Cancer Treatment (Other Treatment Types) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 16: Global: Non-Melanoma Skin Cancer Treatment (Basal Cell Carcinoma) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 17: Global: Non-Melanoma Skin Cancer Treatment (Basal Cell Carcinoma) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 18: Global: Non-Melanoma Skin Cancer Treatment (T-Cell Lymphoma) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 19: Global: Non-Melanoma Skin Cancer Treatment (T-Cell Lymphoma) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 20: Global: Non-Melanoma Skin Cancer Treatment (Squamous Cell Carcinoma) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 21: Global: Non-Melanoma Skin Cancer Treatment (Squamous Cell Carcinoma) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 22: Global: Non-Melanoma Skin Cancer Treatment (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 23: Global: Non-Melanoma Skin Cancer Treatment (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 24: Global: Non-Melanoma Skin Cancer Treatment (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 25: Global: Non-Melanoma Skin Cancer Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 26: Global: Non-Melanoma Skin Cancer Treatment (Specialty Clinics) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 27: Global: Non-Melanoma Skin Cancer Treatment (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 28: Global: Non-Melanoma Skin Cancer Treatment (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 29: Global: Non-Melanoma Skin Cancer Treatment (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 30: Global: Non-Melanoma Skin Cancer Treatment (Other End Uses) Market: Sales Value (in Million US$), 2016 & 2021
- Figure 31: Global: Non-Melanoma Skin Cancer Treatment (Other End Uses) Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 32: North America: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 33: North America: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 34: United States: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 35: United States: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 36: Canada: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 37: Canada: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 38: Asia Pacific: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 39: Asia Pacific: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 40: China: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 41: China: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 42: Japan: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 43: Japan: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 44: India: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 45: India: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 46: South Korea: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 47: South Korea: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 48: Australia: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 49: Australia: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 50: Indonesia: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 51: Indonesia: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 52: Others: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 53: Others: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 54: Europe: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 55: Europe: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 56: Germany: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 57: Germany: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 58: France: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 59: France: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 60: United Kingdom: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 61: United Kingdom: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 62: Italy: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 63: Italy: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 64: Spain: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 65: Spain: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 66: Russia: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 67: Russia: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 68: Others: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 69: Others: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 70: Latin America: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 71: Latin America: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 72: Brazil: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 73: Brazil: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 74: Mexico: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 75: Mexico: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 76: Others: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 77: Others: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 78: Middle East and Africa: Non-Melanoma Skin Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
- Figure 79: Middle East and Africa: Non-Melanoma Skin Cancer Treatment Market: Breakup by Country (in %), 2021
- Figure 80: Middle East and Africa: Non-Melanoma Skin Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
- Figure 81: Global: Non-Melanoma Skin Cancer Treatment Industry: SWOT Analysis
- Figure 82: Global: Non-Melanoma Skin Cancer Treatment Industry: Value Chain Analysis
- Figure 83: Global: Non-Melanoma Skin Cancer Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Non-Melanoma Skin Cancer Treatment Market: Key Industry Highlights, 2021 and 2027
- Table 2: Global: Non-Melanoma Skin Cancer Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
- Table 3: Global: Non-Melanoma Skin Cancer Treatment Market Forecast: Breakup by Indication (in Million US$), 2022-2027
- Table 4: Global: Non-Melanoma Skin Cancer Treatment Market Forecast: Breakup by End Use (in Million US$), 2022-2027
- Table 5: Global: Non-Melanoma Skin Cancer Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
- Table 6: Global: Non-Melanoma Skin Cancer Treatment Market Structure
- Table 7: Global: Non-Melanoma Skin Cancer Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.